Drug intelligence / Profile preview

Yi-Tong Cheng-Zhang probiotics

Development stage: Unknown
Lead developer: Shanghai Children's Medical Center
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Yi-Tong Cheng-Zhang probiotics is a probiotic-based dietary supplement marketed as a solid drink for children in China. It is primarily used to support gastrointestinal health and has been investigated for its potential to mitigate lead toxicity (hyperlead) in pediatric populations. The product is thought to work by utilizing specific probiotic strains that can sequester heavy metals like lead within the gut, thereby reducing intestinal absorption and promoting excretion. A multicenter clinical trial led by the Shanghai Children's Medical Center has evaluated its efficacy in children with elevated blood lead levels, positioning it as a potential microbial therapy for environmental toxin exposure.

Brand names: Yi-Tong Cheng-Zhang益同成长
Other names: Yi-Tong Cheng-Zhang probiotic solid drink益同成长益生菌固体饮料

Beyond the preview

Go deeper on Yi-Tong Cheng-Zhang probiotics.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yi-Tong Cheng-Zhang probiotics.

Explore the full profile